Sangeeta Rojanala

Targeting aurora2 kinase in oncogenesis: a structural bioinformatics approach to target validation and rational drug design.

D. V. Von Hoff, J. Saldanha, D. Bearss, 2003, Molecular cancer therapeutics.

AURORA-A, A POTENTIAL TARGET IN PANCREATIC CANCER AND ITS STRUCTURAL ROLE IN LOCALIZATION TO THE CENTROSOMES

Sangeeta Rojanala, 2005 .

The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer.

Haiyong Han, D. V. Von Hoff, R. Nagle, 2004, Molecular cancer therapeutics.